Resmed (RSMDF) EBT (2009 - 2026)

Resmed has reported EBT for 18 years, with the latest figure at $502.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 20.26% year-over-year to $502.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 20.67% YoY), and the FY2025 full-year result was $1.7 billion, up 32.64% from the prior year.
• EBT for Q1 2026 stood at $502.3 million, up from $496.1 million in the prior quarter.
• The five-year high for EBT was $502.3 million in Q1 2026, with the low at $226.3 million in Q1 2022.
• Historically, EBT has averaged $350.2 million across 5 years, with a median of $357.7 million in 2024.
• Annual changes were most pronounced in 2023 — EBT retreated 5.2% — and 2024, when it jumped 61.23%.
• Resmed's EBT stood at $273.7 million in 2022, then decreased by 5.2% to $259.5 million in 2023, then surged by 61.23% to $418.3 million in 2024, then increased by 18.6% to $496.1 million in 2025, then climbed by 1.24% to $502.3 million in 2026.
• The last three EBT figures came in at $502.3 million (Q1 2026), $496.1 million (Q4 2025), and $446.8 million (Q3 2025), per Business Quant data.